Top Posters
Since Sunday
57
52
27
18
16
16
15
14
14
14
14
13
New Topic  
wrote...
Posts: 28
Rep: 0 0
2 months ago
A patient is administered aztreonam (Azactam). What is the major advantage of this monobactam over the aminoglycosides in treating P. aeruginosa?
A)It is a lower-cost medication.
B)It is administered orally.
C)It causes less GI distress.
D)It has lower risk for hearing loss.
Source  Download
Abrams' Clinical Drug Therapy: Rationales for Nursing Practice
Edition: 10th
Authors:
Read 11 times
1 Reply
Replies
Answer verified by a subject expert
wrote...
Posts: 160
2 months ago
Sign in or Sign up in seconds to unlock everything.
D
Feedback:
Aztreonam is effective against gram-negative bacteria similar to aminoglycosides, but the drug does not cause kidney damage or hearing loss. Aztreonam is not a lower-cost medication. Aztreonam is not administered orally. Aztreonam does not cause less GI upset.

1
Related Topics
New Topic      
Explore
Post your homework questions and get free online help from our incredible volunteers.
Learn More
Improve Grades
Help Others
Save Time
Accessible 24/7
  327 People Browsing
Related Images
 92
 95

▶️ Video: Automated external defibrillator (AED)

For a complete list of videos, visit our video library